Evidence map›Paper›PMID 42221590›Full record

ArticleFrontiers in cellular and infection microbiology2026

Genomic analysis reveals multi-level resistance network linking oxidative stress pathway mutations to cefiderocol resistance and clonal evolution in

Lana Daoud, Timothy Collyns, Akela Ghazawi, Farah Al-Marzooq

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lana DaoudDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Timothy CollynsTawam Hospital, Al-Ain, United Arab Emirates.
Akela GhazawiDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
Farah Al-MarzooqDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Resistance to cefiderocol (CFDC), a novel siderophore-cephalosporin, remains poorly understood. We aimed to explore mutations in oxidative stress (OS) pathways in Methods: A total of 282 KPN strains from the United Arab Emirates were tested for susceptibility to various antibiotics, including CFDC. Afterward, 96 representative strains were subjected to whole-genome sequencing and bioinformatic analyses to examine 51 genes across six functional categories (OxyR, SoxRS, iron regulation, efflux pumps, DNA repair, and penicillin-binding proteins). Genotypic and phenotypic results were correlated to explore significant associations with CFDC susceptibility. Results: CFDC demonstrated high Conclusions: Coordinated interactions across iron regulation, OS, and efflux pathways are associated with reduced susceptibility to CFDC. The negative correlation between OxyR/DNA repair mutations and CFDC MICs suggests that intact OS defenses paradoxically reduce CFDC efficacy. OS pathway integrity may modulate CFDC susceptibility, informing future strategies to preserve CFDC efficacy. The identification of specific mutations linked to CFDC resistance provides potential biomarkers for surveillance and therapeutic targeting, underscoring the interplay between OS responses and antimicrobial resistance.

Indexed as

Anti-Bacterial AgentsCephalosporinsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialKlebsiella pneumoniaeMutationOxidative StressBacterial ProteinsCefiderocolGenome, BacterialGenomicsGenotypeHumansKlebsiella InfectionsMicrobial Sensitivity TestsUnited Arab EmiratesAnti-Bacterial AgentsBacterial ProteinsCefiderocolCephalosporinsantimicrobial resistancecefiderocoliron transportKlebsiella pneumoniaeoxidative stressUAEwhole-genome sequencing

Identifiers

PMID42221590
PMCPMC13219037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.